Literature DB >> 19293954

The silver lining of recent effectiveness trials.

Alan F Schatzberg1.   

Abstract

Year:  2009        PMID： 19293954      PMCID： PMC2645008          DOI： 10.1002/j.2051-5545.2009.tb00203.x

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  8 in total

1.  Efficient trial designs to reduce placebo requirements.

Authors:  K R Krishnan
Journal:  Biol Psychiatry       Date:  2000-04-15       Impact factor: 13.382

2.  Moderators of treatment outcomes: clinical, research, and policy importance.

Authors:  Helena C Kraemer; Ellen Frank; David J Kupfer
Journal:  JAMA       Date:  2006-09-13       Impact factor: 56.272

3.  Pharmacogenetics of antidepressant medication intolerance.

Authors:  Greer M Murphy; Charlotte Kremer; Heidi E Rodrigues; Alan F Schatzberg
Journal:  Am J Psychiatry       Date:  2003-10       Impact factor: 18.112

4.  The FKBP5-gene in depression and treatment response--an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Cohort.

Authors:  Magnus Lekman; Gonzalo Laje; Dennis Charney; A John Rush; Alexander F Wilson; Alexa J M Sorant; Robert Lipsky; Stephen R Wisniewski; Husseini Manji; Francis J McMahon; Silvia Paddock
Journal:  Biol Psychiatry       Date:  2008-01-11       Impact factor: 13.382

5.  Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

Authors:  A John Rush; Madhukar H Trivedi; Stephen R Wisniewski; Jonathan W Stewart; Andrew A Nierenberg; Michael E Thase; Louise Ritz; Melanie M Biggs; Diane Warden; James F Luther; Kathy Shores-Wilson; George Niederehe; Maurizio Fava
Journal:  N Engl J Med       Date:  2006-03-23       Impact factor: 91.245

6.  Medication augmentation after the failure of SSRIs for depression.

Authors:  Madhukar H Trivedi; Maurizio Fava; Stephen R Wisniewski; Michael E Thase; Frederick Quitkin; Diane Warden; Louise Ritz; Andrew A Nierenberg; Barry D Lebowitz; Melanie M Biggs; James F Luther; Kathy Shores-Wilson; A John Rush
Journal:  N Engl J Med       Date:  2006-03-23       Impact factor: 91.245

7.  Ethnic stratification of the association of RGS4 variants with antipsychotic treatment response in schizophrenia.

Authors:  Daniel B Campbell; Philip J Ebert; Tara Skelly; T Scott Stroup; Jeffrey Lieberman; Pat Levitt; Patrick F Sullivan
Journal:  Biol Psychiatry       Date:  2007-06-22       Impact factor: 13.382

8.  Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study.

Authors:  Roy H Perlis; Shaun Purcell; Maurizio Fava; Jesen Fagerness; A John Rush; Madhukar H Trivedi; Jordan W Smoller
Journal:  Arch Gen Psychiatry       Date:  2007-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.